The article discusses the efficacy and clinical durability of EUS-guided gallbladder drainage (EUS-GBD) as a treatment for acute cholecystitis in high-risk surgical patients. Acute cholecystitis, which is an inflammation of the gallbladder, is traditionally treated with surgical intervention.
The article discusses the efficacy and clinical durability of EUS-guided gallbladder drainage (EUS-GBD) as a treatment for acute cholecystitis in high-risk surgical patients. Acute cholecystitis, which is an inflammation of the gallbladder, is traditionally treated with surgical intervention. However, in patients who are not candidates for surgery due to high risk, EUS-GBD has emerged as a reliable alternative. This minimally invasive procedure has been supported by recent guidelines over percutaneous transhepatic gallbladder drainage (PTGBD) in such cases.
The study systematically analyzed data from 18 studies, including 701 patients, with follow-up periods exceeding 1 year. The technical success rate of EUS-GBD was 95.8%, and the clinical success rate was 94.3%. Recurrence of cholecystitis was low (4.2%), while readmission rates were 19% and reintervention rates were 6%. Stent patency was observed for an average of 418.8 days, and the need for repeat endoscopy due to stent obstruction or occlusion was minimal (2.9%). Overall, the procedure showed a low rate of adverse events.
In conclusion, EUS-GBD is a technically effective, clinically durable, and safe treatment for acute cholecystitis in high-risk patients, offering a viable alternative to traditional surgical approaches with sustained long-term outcomes.
Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase II trial evaluated ivonescimab, a novel PD-1/VEGF...
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However, concerns remain regarding their potential association with...
Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic duct (PD) dilatation is commonly detected during...
• This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. • Most clinically relevant cases were grade B, while no grade C leaks were reported. • A minimally invasive surgical...
Introduction: Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Fatty pancreas disease (FPD), also known as intrapancreatic fat deposition, has emerged as an important metabolic condition closely linked to obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Although ectopic fat accumulation in...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.